Erin Bertino

Academic / Other · 2 registered clinical trials.

Status	Trial	Phase	Started
Withdrawn	Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma	Phase 1 / Phase 2	2015-09-01
Terminated	Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer Recurrent Small Cell Lung Carcinoma	Phase 2	2015-05-01